Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
37โ€“38
Headlines
38
Sources here
1
Companies here
2
Current section China Healthcare news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Deals and strategy Provider-linked mention ๐Ÿ‡จ๐Ÿ‡ณ China

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

SHANGHAI, July 27, 2026 /PRNewswire/ -- AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), today announced that construction of its new R&D building has officially broken ground at the Shanghai Fengxian site. โ€ฆ

002821 mentioned
Sharemaestro market context Trend signal active 52 weeks +65.5% ยท Next-week setup negative 41.6% 002821 stored weekly price path from 26 Sep 2025 to 25 Sep 2026
finance.yahoo.com Regulatory and legal Main company ๐Ÿ‡จ๐Ÿ‡ณ China

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage โ…ก-โ…ข NSCLC

Junshi Biosciences SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental application for toripalimab in combination โ€ฆ

688180 main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% 688180 stored weekly price path from 26 Sep 2025 to 25 Sep 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context